Cargando…
Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
BACKGROUND: Endoglin is involved in the regulation of endothelial function, but there are no studies concerning its relation with hypertension- and diabetes-associated pathologies. Thus, we studied the relationship between plasma levels of soluble endoglin and cardiovascular alterations associated w...
Autores principales: | Blázquez-Medela, Ana M, García-Ortiz, Luis, Gómez-Marcos, Manuel A, Recio-Rodríguez, José I, Sánchez-Rodríguez, Angel, López-Novoa, José M, Martínez-Salgado, Carlos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012013/ https://www.ncbi.nlm.nih.gov/pubmed/21171985 http://dx.doi.org/10.1186/1741-7015-8-86 |
Ejemplares similares
-
Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients
por: Gómez-Marcos, Manuel A., et al.
Publicado: (2016) -
Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities
por: Pérez-Roque, Lucía, et al.
Publicado: (2020) -
Circulating soluble endoglin modifies the inflammatory response in mice
por: Ruiz-Remolina, Laura, et al.
Publicado: (2017) -
Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk
por: Gamella-Pozuelo, Luis, et al.
Publicado: (2015) -
Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage
por: Garzon-Martinez, Mercedes, et al.
Publicado: (2020)